Joseph Palumbo

Technik-/Wissenschafts-/F&E-Leiter bei BIOVIE INC.

Vermögen: 3 633 $ am 30.04.2024

64 Jahre

Health Technology

Consumer Services

Retail Trade

Aktive Positionen von Joseph Palumbo

Unternehmen	Position	Beginn	Ende
BIOVIE INC.	Technik-/Wissenschafts-/F&E-Leiter	01.11.2021	-
HYDREIGHT TECHNOLOGIES INC.	Direktor/Vorstandsmitglied	25.11.2022	-

Unternehmen	Position	Beginn	Ende
ZYNERBA PHARMACEUTICALS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.07.2019	01.10.2021
JOHNSON & JOHNSON	Corporate Officer/Principal	-	-
MITSUBISHI TANABE PHARMA CORPORATION	Corporate Officer/Principal	-	-

University of Pennsylvania Graduate School of Education	Undergraduate Degree
George Washington University School of Medicine & Health	Doctorate Degree

International

Operativ

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	2
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
ZYNERBA PHARMACEUTICALS, INC.	Health Technology
JOHNSON & JOHNSON	Health Technology
BIOVIE INC.	Health Technology
HYDREIGHT TECHNOLOGIES INC.	Retail Trade

Private Unternehmen	1
Mitsubishi Tanabe Pharma Corp. Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.	Health Technology

Private Unternehmen

Health Technology